ID   PTPRM_HUMAN             Reviewed;        1452 AA.
AC   P28827; A7MBN1; D3DUH8; J3QL11;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   10-MAY-2017, entry version 186.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase mu;
DE            Short=Protein-tyrosine phosphatase mu;
DE            Short=R-PTP-mu;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=PTPRM; Synonyms=PTPRL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1655529; DOI=10.1016/0014-5793(91)81241-Y;
RA   Gebbink M.F.B.G., van Etten I., Hateboer G., Suijkerbuijk R.,
RA   Beijersbergen R., Geurts van Kessel A., Moolenaar W.H.;
RT   "Cloning, expression and chromosomal localization of a new putative
RT   receptor-like protein tyrosine phosphatase.";
RL   FEBS Lett. 290:123-130(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-131.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-821, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 879-1156.
RX   PubMed=9346878; DOI=10.1074/jbc.272.44.27505;
RA   Hoffmann K.M., Tonks N.K., Barford D.;
RT   "The crystal structure of domain 1 of receptor protein-tyrosine
RT   phosphatase mu.";
RL   J. Biol. Chem. 272:27505-27508(1997).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 21-279, FUNCTION, AND
RP   DISULFIDE BONDS.
RX   PubMed=16456543; DOI=10.1038/sj.emboj.7600974;
RA   Aricescu A.R., Hon W.-C., Siebold C., Lu W., van der Merwe P.A.,
RA   Jones E.Y.;
RT   "Molecular analysis of receptor protein tyrosine phosphatase mu-
RT   mediated cell adhesion.";
RL   EMBO J. 25:701-712(2006).
CC   -!- FUNCTION: Involved in cell-cell adhesion through homophilic
CC       interactions. May play a key role in signal transduction and
CC       growth control. {ECO:0000269|PubMed:16456543}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-2257317, EBI-2257317;
CC       P09803:Cdh1 (xeno); NbExp=3; IntAct=EBI-2257317, EBI-984420;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28827-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28827-2; Sequence=VSP_046677;
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58288; CAA41226.1; -; mRNA.
DR   EMBL; AC006566; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000897; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001091; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005118; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005227; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005900; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471113; EAX01623.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01624.1; -; Genomic_DNA.
DR   EMBL; BC151842; AAI51843.1; -; mRNA.
DR   CCDS; CCDS11840.1; -. [P28827-1]
DR   CCDS; CCDS58613.1; -. [P28827-2]
DR   PIR; S17669; S17669.
DR   RefSeq; NP_001098714.1; NM_001105244.1. [P28827-2]
DR   RefSeq; NP_002836.3; NM_002845.3. [P28827-1]
DR   UniGene; Hs.49774; -.
DR   PDB; 1RPM; X-ray; 2.30 A; A/B=879-1156.
DR   PDB; 2C9A; X-ray; 2.70 A; A=21-279.
DR   PDB; 2V5Y; X-ray; 3.10 A; A=21-742.
DR   PDBsum; 1RPM; -.
DR   PDBsum; 2C9A; -.
DR   PDBsum; 2V5Y; -.
DR   ProteinModelPortal; P28827; -.
DR   SMR; P28827; -.
DR   BioGrid; 111761; 2.
DR   DIP; DIP-668N; -.
DR   IntAct; P28827; 5.
DR   MINT; MINT-128128; -.
DR   STRING; 9606.ENSP00000331418; -.
DR   BindingDB; P28827; -.
DR   ChEMBL; CHEMBL4661; -.
DR   GuidetoPHARMACOLOGY; 1860; -.
DR   DEPOD; P28827; -.
DR   iPTMnet; P28827; -.
DR   PhosphoSitePlus; P28827; -.
DR   BioMuta; PTPRM; -.
DR   DMDM; 206729890; -.
DR   EPD; P28827; -.
DR   MaxQB; P28827; -.
DR   PaxDb; P28827; -.
DR   PeptideAtlas; P28827; -.
DR   PRIDE; P28827; -.
DR   Ensembl; ENST00000332175; ENSP00000331418; ENSG00000173482. [P28827-1]
DR   Ensembl; ENST00000580170; ENSP00000463325; ENSG00000173482. [P28827-2]
DR   GeneID; 5797; -.
DR   KEGG; hsa:5797; -.
DR   UCSC; uc002knn.5; human. [P28827-1]
DR   CTD; 5797; -.
DR   DisGeNET; 5797; -.
DR   GeneCards; PTPRM; -.
DR   H-InvDB; HIX0027374; -.
DR   HGNC; HGNC:9675; PTPRM.
DR   HPA; CAB022442; -.
DR   HPA; CAB022443; -.
DR   HPA; HPA003891; -.
DR   MIM; 176888; gene.
DR   neXtProt; NX_P28827; -.
DR   OpenTargets; ENSG00000173482; -.
DR   PharmGKB; PA34020; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOGENOM; HOG000049029; -.
DR   HOVERGEN; HBG062785; -.
DR   InParanoid; P28827; -.
DR   KO; K05693; -.
DR   OMA; NWEQVNT; -.
DR   OrthoDB; EOG091G00CK; -.
DR   PhylomeDB; P28827; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   ChiTaRS; PTPRM; human.
DR   EvolutionaryTrace; P28827; -.
DR   GeneWiki; PTPRM; -.
DR   GenomeRNAi; 5797; -.
DR   PRO; PR:P28827; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000173482; -.
DR   CleanEx; HS_PTPRM; -.
DR   ExpressionAtlas; P28827; baseline and differential.
DR   Genevisible; P28827; HS.
DR   GO; GO:0005913; C:cell-cell adherens junction; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0045296; F:cadherin binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; IDA:UniProtKB.
DR   GO; GO:0097755; P:positive regulation of blood vessel diameter; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0010842; P:retina layer formation; IMP:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 5.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Hydrolase; Immunoglobulin domain;
KW   Membrane; Phosphoprotein; Polymorphism; Protein phosphatase; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21   1452       Receptor-type tyrosine-protein
FT                                phosphatase mu.
FT                                /FTId=PRO_0000025448.
FT   TOPO_DOM     21    742       Extracellular. {ECO:0000255}.
FT   TRANSMEM    743    764       Helical. {ECO:0000255}.
FT   TOPO_DOM    765   1452       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       22    184       MAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00128}.
FT   DOMAIN      186    277       Ig-like C2-type.
FT   DOMAIN      284    379       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      382    480       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      482    587       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      589    671       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      900   1154       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1186   1448       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1095   1101       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1095   1095       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE   1389   1389       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1063   1063       Substrate. {ECO:0000250}.
FT   BINDING    1139   1139       Substrate. {ECO:0000250}.
FT   MOD_RES     821    821       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CARBOHYD     72     72       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    131    131       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    249    249       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    454    454       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    534    534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    544    544       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    651    651       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    681    681       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     27     36       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:16456543}.
FT   DISULFID     96    182       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:16456543}.
FT   DISULFID    206    260       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:16456543}.
FT   VAR_SEQ     842    842       P -> PDPFVPTAILVPIN (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046677.
FT   VARIANT      39     39       S -> R (in dbSNP:rs35224276).
FT                                /FTId=VAR_046634.
FT   CONFLICT      3      3       G -> T (in Ref. 1; CAA41226).
FT                                {ECO:0000305}.
FT   CONFLICT     68     68       F -> L (in Ref. 1; CAA41226).
FT                                {ECO:0000305}.
FT   CONFLICT   1300   1300       P -> L (in Ref. 4; AAI51843).
FT                                {ECO:0000305}.
FT   CONFLICT   1384   1384       R -> P (in Ref. 1; CAA41226).
FT                                {ECO:0000305}.
FT   STRAND       29     31       {ECO:0000244|PDB:2C9A}.
FT   HELIX        33     36       {ECO:0000244|PDB:2C9A}.
FT   STRAND       42     45       {ECO:0000244|PDB:2C9A}.
FT   STRAND       49     52       {ECO:0000244|PDB:2C9A}.
FT   TURN         53     55       {ECO:0000244|PDB:2C9A}.
FT   STRAND       66     72       {ECO:0000244|PDB:2C9A}.
FT   STRAND       81     85       {ECO:0000244|PDB:2C9A}.
FT   STRAND       96    104       {ECO:0000244|PDB:2C9A}.
FT   STRAND      106    109       {ECO:0000244|PDB:2C9A}.
FT   STRAND      111    120       {ECO:0000244|PDB:2C9A}.
FT   STRAND      129    132       {ECO:0000244|PDB:2C9A}.
FT   STRAND      140    147       {ECO:0000244|PDB:2C9A}.
FT   STRAND      155    163       {ECO:0000244|PDB:2C9A}.
FT   STRAND      169    180       {ECO:0000244|PDB:2C9A}.
FT   STRAND      183    185       {ECO:0000244|PDB:2C9A}.
FT   STRAND      194    196       {ECO:0000244|PDB:2C9A}.
FT   STRAND      198    200       {ECO:0000244|PDB:2C9A}.
FT   STRAND      202    210       {ECO:0000244|PDB:2C9A}.
FT   STRAND      217    222       {ECO:0000244|PDB:2C9A}.
FT   STRAND      230    237       {ECO:0000244|PDB:2C9A}.
FT   STRAND      240    247       {ECO:0000244|PDB:2C9A}.
FT   HELIX       252    254       {ECO:0000244|PDB:2C9A}.
FT   STRAND      256    264       {ECO:0000244|PDB:2C9A}.
FT   STRAND      267    278       {ECO:0000244|PDB:2C9A}.
FT   STRAND      284    286       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      289    293       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      298    301       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      305    309       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      315    326       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      328    332       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      335    340       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      348    356       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      370    373       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      384    391       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      396    401       {ECO:0000244|PDB:2V5Y}.
FT   HELIX       405    408       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      410    412       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      414    434       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      443    446       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      454    462       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      467    469       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      473    476       {ECO:0000244|PDB:2V5Y}.
FT   TURN        487    489       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      491    495       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      498    502       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      515    525       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      536    542       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      547    550       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      557    567       {ECO:0000244|PDB:2V5Y}.
FT   STRAND      570    580       {ECO:0000244|PDB:2V5Y}.
FT   TURN        882    884       {ECO:0000244|PDB:1RPM}.
FT   HELIX       885    905       {ECO:0000244|PDB:1RPM}.
FT   TURN        916    919       {ECO:0000244|PDB:1RPM}.
FT   HELIX       921    926       {ECO:0000244|PDB:1RPM}.
FT   HELIX       936    938       {ECO:0000244|PDB:1RPM}.
FT   STRAND      939    941       {ECO:0000244|PDB:1RPM}.
FT   TURN        949    952       {ECO:0000244|PDB:1RPM}.
FT   STRAND      953    961       {ECO:0000244|PDB:1RPM}.
FT   STRAND      964    971       {ECO:0000244|PDB:1RPM}.
FT   HELIX       976    978       {ECO:0000244|PDB:1RPM}.
FT   HELIX       979    988       {ECO:0000244|PDB:1RPM}.
FT   STRAND      993    996       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1000   1002       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1014   1019       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1022   1032       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1035   1044       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1051   1058       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1063   1065       {ECO:0000244|PDB:1RPM}.
FT   HELIX      1071   1083       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1091   1099       {ECO:0000244|PDB:1RPM}.
FT   HELIX      1100   1118       {ECO:0000244|PDB:1RPM}.
FT   STRAND     1119   1121       {ECO:0000244|PDB:1RPM}.
FT   HELIX      1123   1133       {ECO:0000244|PDB:1RPM}.
FT   HELIX      1141   1155       {ECO:0000244|PDB:1RPM}.
SQ   SEQUENCE   1452 AA;  163682 MW;  8319E3D3A583E992 CRC64;
     MRGLGTCLAT LAGLLLTAAG ETFSGGCLFD EPYSTCGYSQ SEGDDFNWEQ VNTLTKPTSD
     PWMPSGSFML VNASGRPEGQ RAHLLLPQLK ENDTHCIDFH YFVSSKSNSP PGLLNVYVKV
     NNGPLGNPIW NISGDPTRTW NRAELAISTF WPNFYQVIFE VITSGHQGYL AIDEVKVLGH
     PCTRTPHFLR IQNVEVNAGQ FATFQCSAIG RTVAGDRLWL QGIDVRDAPL KEIKVTSSRR
     FIASFNVVNT TKRDAGKYRC MIRTEGGVGI SNYAELVVKE PPVPIAPPQL ASVGATYLWI
     QLNANSINGD GPIVAREVEY CTASGSWNDR QPVDSTSYKI GHLDPDTEYE ISVLLTRPGE
     GGTGSPGPAL RTRTKCADPM RGPRKLEVVE VKSRQITIRW EPFGYNVTRC HSYNLTVHYC
     YQVGGQEQVR EEVSWDTENS HPQHTITNLS PYTNVSVKLI LMNPEGRKES QELIVQTDED
     LPGAVPTESI QGSTFEEKIF LQWREPTQTY GVITLYEITY KAVSSFDPEI DLSNQSGRVS
     KLGNETHFLF FGLYPGTTYS FTIRASTAKG FGPPATNQFT TKISAPSMPA YELETPLNQT
     DNTVTVMLKP AHSRGAPVSV YQIVVEEERP RRTKKTTEIL KCYPVPIHFQ NASLLNSQYY
     FAAEFPADSL QAAQPFTIGD NKTYNGYWNT PLLPYKSYRI YFQAASRANG ETKIDCVQVA
     TKGAATPKPV PEPEKQTDHT VKIAGVIAGI LLFVIIFLGV VLVMKKRKLA KKRKETMSST
     RQEMTVMVNS MDKSYAEQGT NCDEAFSFMD THNLNGRSVS SPSSFTMKTN TLSTSVPNSY
     YPDETHTMAS DTSSLVQSHT YKKREPADVP YQTGQLHPAI RVADLLQHIT QMKCAEGYGF
     KEEYESFFEG QSAPWDSAKK DENRMKNRYG NIIAYDHSRV RLQTIEGDTN SDYINGNYID
     GYHRPNHYIA TQGPMQETIY DFWRMVWHEN TASIIMVTNL VEVGRVKCCK YWPDDTEIYK
     DIKVTLIETE LLAEYVIRTF AVEKRGVHEI REIRQFHFTG WPDHGVPYHA TGLLGFVRQV
     KSKSPPSAGP LVVHCSAGAG RTGCFIVIDI MLDMAEREGV VDIYNCVREL RSRRVNMVQT
     EEQYVFIHDA ILEACLCGDT SVPASQVRSL YYDMNKLDPQ TNSSQIKEEF RTLNMVTPTL
     RVEDCSIALL PRNHEKNRCM DILPPDRCLP FLITIDGESS NYINAALMDS YKQPSAFIVT
     QHPLPNTVKD FWRLVLDYHC TSVVMLNDVD PAQLCPQYWP ENGVHRHGPI QVEFVSADLE
     EDIISRIFRI YNAARPQDGY RMVQQFQFLG WPMYRDTPVS KRSFLKLIRQ VDKWQEEYNG
     GEGRTVVHCL NGGGRSGTFC AISIVCEMLR HQRTVDVFHA VKTLRNNKPN MVDLLDQYKF
     CYEVALEYLN SG
//
